Gene C. Mack
Director of Finance/CFO chez GAIN THERAPEUTICS, INC.
Profil
Mr. Gene C.
Mack is a Chief Financial Officer & Secretary at Gain Therapeutics, Inc. Mr. Mack was previously employed as a Chief Financial Officer by ImCyse SA, a Chief Financial Officer & Treasurer by SELLAS Life Sciences Group, Inc., a Chief Financial Officer & Senior Vice President by Ascendia Pharmaceuticals, Inc., a Senior Director-Finance & Investor Relations by Edge Therapeutics, Inc., a Managing Director by Brean Capital LLC, an Executive Director by MIZUHO SECURITIES USA INC, a Research Analyst by Soleil Securities Corp., a Research Analyst by Lazard Capital Markets LLC, an Analyst by HSBC Securities (USA), Inc., an Analyst by Gruntal & Co. LLC, a Chief Financial Officer by OncoC4, Inc., and an Analyst by Ryan, Beck & Co., Inc. He received his undergraduate degree from Fordham University and an MBA from Fordham University.
Postes actifs de Gene C. Mack
| Sociétés | Poste | Début |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Director of Finance/CFO | 08/04/2024 |
Anciens postes connus de Gene C. Mack
| Sociétés | Poste | Fin |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Director of Finance/CFO | 01/10/2023 |
| SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 17/12/2018 |
Ascendia Pharmaceuticals, Inc.
 Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ascendia Pharmaceuticals LLC engages in the invention and development of specialty pharmaceutical products and novel formulation technologies. It offers rapid development and special development programs. The company was founded by Jingjun Huang in 2012 and is headquartered in North Brunswick, NJ. | Director of Finance/CFO | 01/01/2017 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Investor Relations Contact | 01/01/2015 |
Brean Capital LLC
 Brean Capital LLC Investment Banks/BrokersFinance Brean Capital is an independent investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1973 and provides equity research, corporate finance and advisory investment banking, equity institutional sales and trading, and asset management to institutional investors and corporate clients. Their fixed income business provides sales, trading, research and banking services on a wide range of mortgage and asset-backed, US Treasury and government agency securities, structured products, corporate bonds, and municipal debt. The fixed income sales team employs a highly analytical approach to bond selection, trade execution, and overall bond portfolio management. Under the guidance of fixed income strategists, the fixed income team uses a combination of qualitative and quantitative analyses to create custom investment portfolios and develop targeted, executable bond trading strategies to complement their clients? balance sheets. | Analyst-Equity | 01/03/2014 |
Formation de Gene C. Mack
| Fordham University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Ryan, Beck & Co., Inc.
 Ryan, Beck & Co., Inc. Investment Banks/BrokersFinance Ryan, Beck & Co., Inc. was founded in 1946. They are headquartered in Florham Park, New Jersey with additional offices in Atlanta, Georgia, Boca Raton, Florida, Conshohocken, Pennsylvania, New York City, and Richmond, Virginia. | Finance |
Soleil Securities Corp.
 Soleil Securities Corp. Investment Banks/BrokersFinance Founded in 2003, Soleil Securities Corp. is a broker/dealer headquartered in New York City. The firm is a subsidiary of Ticonderoga Securities LLC and their ultimate parent is Cayman Islands-based GEROVA Financial Group Ltd. (NYSE: GFC). Soleil Securities Corp. is a member of FINRA and the SIPC. The firm offers in-depth company-specific equity research to institutional clients. They provide coverage across a variety of significant growth sectors of the economy. Soleil Securities Corp.'s research process integrates macroeconomic considerations with investment-relevant policy insights. They seek to produce alpha-generating, actionable information that can help their clients achieve their investment objectives. The firm covers the following industries: (1) basic materials including agricultural chemicals, specialty chemicals and paper/forest products (2) capital goods and industrials including autos and auto parts (3) consumer including gaming, lodging, eTravel, agribusiness, sustainable agriculture, specialty foods, specialty retail, homebuilders and retailing/automotive (4) financial institutions including financial services, property and casualty and regional banks (5) healthcare including pharmaceuticals, medical technology, biotechnology and medical devices (6) special situations (7) strategy and policy (8) technology including software/Internet, semiconductors and solar power (9) telecommunications and telecommunications equipment (10) transportation (11) airlines and (12) utilities | Finance |
Mizuho Securities USA LLC
 Mizuho Securities USA LLC Investment Banks/BrokersFinance Mizuho Securities USA LLC is the US-based securities broker/dealer and futures commission merchant arm of Mizuho Americas LLC, ultimately held by Mizuho Financial Group, Inc. (TYO: 8411, NYSE: MFG) in Japan. Headquartered in New York City, the firm was founded in 1994 and provides institutional and corporate clients access to commodity and financial markets around the world. Mizuho Securities USA covers the following industries: Consumer, Energy, Financial Institutions, Financial Sponsors, Healthcare, Industrial & Diversified Industries, Power, Utilities & Infrastructure, Real Estate, and Technology, Media & Telecom (TMT). The firm and their affiliates hold memberships on all major futures and options exchanges worldwide. | Finance |
HSBC Securities (USA), Inc.
 HSBC Securities (USA), Inc. Investment Banks/BrokersFinance Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities. | Finance |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Finance |
| Gruntal & Co. LLC | Government |
Brean Capital LLC
Brean Capital LLC Investment Banks/BrokersFinance Brean Capital is an independent investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1973 and provides equity research, corporate finance and advisory investment banking, equity institutional sales and trading, and asset management to institutional investors and corporate clients. Their fixed income business provides sales, trading, research and banking services on a wide range of mortgage and asset-backed, US Treasury and government agency securities, structured products, corporate bonds, and municipal debt. The fixed income sales team employs a highly analytical approach to bond selection, trade execution, and overall bond portfolio management. Under the guidance of fixed income strategists, the fixed income team uses a combination of qualitative and quantitative analyses to create custom investment portfolios and develop targeted, executable bond trading strategies to complement their clients? balance sheets. | Finance |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Ascendia Pharmaceuticals, Inc.
Ascendia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ascendia Pharmaceuticals LLC engages in the invention and development of specialty pharmaceutical products and novel formulation technologies. It offers rapid development and special development programs. The company was founded by Jingjun Huang in 2012 and is headquartered in North Brunswick, NJ. | Health Technology |
| Oncoc4, Inc. |
